February 2024
The asthma drugs market was estimated at USD 23.93 billion in 2023 and is predicted to reach over USD 39.35 billion by 2033, growing at a CAGR of 5.09% from 2024 to 2033.
February 2024
The U.S. over the counter (OTC) drugs market size is projected to hit around USD 41.72 billion by 2033 from USD 23.03 billion in 2023, with a CAGR of 6.42%.
February 2024
The global generic drugs market size was valued at USD 464.98 billion in 2023 and is projected to hit around USD 776.78 billion by 2033, growing at a CAGR of 5.2% over the forecast period from 2024 to 2033.
September 2024
The global market size is predicted to increase from USD 36.22 billion in 2024 to approximately USD 66.16 billion by 2034, expanding at a CAGR of 6.21%.
September 2024
The global atrial fibrillation drugs market size is estimated to surpass around USD 20.99 billion by 2034 from USD 15.59 billion in 2024, with a CAGR of 3.02%.
August 2024
The oncology/cancer drugs market size is calculated at USD 172.39 billion in 2024 and is projected to hit around USD 507.68 billion by 2034 with a CAGR of 11.41%.
March 2024
The global over the counter (OTC) drugs market size was valued at USD 125.28 billion in 2023 and is expected to reach over USD 229.01 billion by 2033 with a CAGR of 6.51% from 2024 to 2033.
October 2024
The global immunotherapy drugs market size is calculated at USD 270.2 billion in 2024 and is projected to hit around USD 1,414.16 billion by 2034, with a CAGR of 18%.
October 2024
The head and neck cancer drugs market size accounted for USD 1.90 billion in 2024 and is expected to reach over USD 4.06 billion by 2034, at a CAGR of 7.88%.
October 2023
The global asthma and COPD drugs market size was estimated at US$ 36 billion in 2022 and is expected to hit US$ 58.92 billion by 2032, growing at a CAGR of 5.10%.
June 2024
The global contraceptive drugs market size was valued at USD 16.94 billion in 2023 and is expected to hit around USD 30.06 billion by 2033, at a CAGR of 5.9%.
June 2024
The global rheumatoid arthritis drugs market size was estimated at USD 62.1 billion in 2023 and is expected to hit USD 74.23 billion by 2033, at a CAGR of 1.8%.
June 2024
The global cardiovascular drugs market size was valued at USD 144.11 billion in 2023 and is expected to reach around USD 207.78 billion by 2033, poised to grow at a compound annual growth rate (CAGR) of 4% over the forecast period 2024 to 2033.
March 2024
The global antipsychotic drugs market size was valued at USD 17.43 billion in 2023 and is anticipated to reach around USD 31.37 billion by 2033, growing at a CAGR of 6.05% from 2024 to 2033.
December 2024
The global orphan drugs market size is estimated at USD 193.01 billion in 2024 and is anticipated to reach around USD 610.24 billion by 2034, expanding at a CAGR of 12.20% from 2024 to 2034.
December 2024
The global dermatology drugs market size is projected to hit around USD 56.27 billion by 2033 from USD 19.22 billion in 2023 with a CAGR of 11.32%.
September 2024
The global anti-obesity drugs market size is estimated to hit around USD 55.25 billion by 2034 increasing from USD 5.69 billion in 2024, with a CAGR of 5.53%.
August 2024
The global veterinary dermatology drugs market size is calculated at USD 8.20 billion in 2024 and is projected to hit around USD 19.28 billion by 2034 with a CAGR of 8.93%.
April 2024
The global ophthalmic drugs market size was estimated at USD 41.17 billion in 2023 and is projected to hit around USD 68.90 billion by 2033 with a CAGR of 5.33%.
February 2024
The U.S. generic drugs market size was evaluated at USD 133.44 billion in 2023 and is projected to hit around USD 189.77 billion by 2033 with a CAGR of 3.5%.
June 2024
The global pain management drugs market size was estimated at USD 81.15 billion in 2023 and is projected to hit around USD 120.16 billion by 2033 at a CAGR of 4% from 2024 to 2033.
July 2024
The global intravenous iron drugs market size accounted for USD 3.53 billion in 2023 and is predicted to hit around USD 8.19 billion by 2034 at a CAGR of 8.8%.
November 2024
The global nephrology drugs market size is estimated at USD 17.71 billion in 2024 and is anticipated to reach around USD 30.30 billion by 2034, expanding at a CAGR of 5.52% from 2024 to 2034.
December 2024
The global antifungal drugs market size is calculated at USD 17.39 billion in 2024 and is projected to surpass around USD 24.51 billion by 2034, growing at a CAGR of 3.49% from 2024 to 2034.
September 2024
The global cancer supportive care drugs market size is projected to hit around USD 26.90 billion by 2034 from USD 21.85 billion in 2024 with a CAGR of 2.1%.
July 2024
The omega 3 prescription drugs market size accounted for USD 1.44 billion in 2024 and is predicted to hit around USD 2.93 billion by 2034 with a CAGR of 7.37%.
November 2024
The global general anesthesia drugs market size was valued at USD 5.40 billion in 2024 and is expected to hit around USD 7.79 billion by 2034, with a CAGR of 3.72%.
July 2024
The atopic dermatitis drugs market size is calculated at USD 14.72 billion in 2022 and is projected to hit around USD 27.33 billion by 2032 with a CAGR of 8.1%.
October 2024
The global hyperlipidemia drugs market size is expected to be valued at USD 22.93 billion in 2024 and is anticipated to reach around USD 33.94 billion by 2034, expanding at a CAGR of 4% over the forecast period from 2024 to 2034.
October 2024
The global pediatric drugs market size was estimated at USD 145.53 billion in 2024 and is projected to hit around USD 460.12 billion by 2034, registering a CAGR of 12.20% from 2024 to 2034.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com